Related Experiment Video
Updated: Jul 13, 2026
05:35
Transperineal Prostate Biopsy Using a Cone-shaped Double-hole Method with Dual-plane Probe Guidance
Published on: June 6, 2025
[Modern methods of prostate cancer diagnostics]
Biomeditsinskaia Khimiia
|July 21, 2007
Summary
This review covers non-invasive immunochemical and molecular-genetic tests for prostate cancer detection and therapy monitoring. It evaluates their potential clinical applications for improved patient outcomes.
Area of Science:
- Biomarkers and Diagnostics
- Oncology
- Translational Medicine
Context:
- Prostate cancer diagnosis and treatment monitoring require accurate and minimally invasive methods.
- Current diagnostic approaches have limitations in specificity and sensitivity.
- The need for effective tools to assess therapeutic response in real-time is critical.
Purpose:
- To review the analytical capabilities of immunochemical and molecular-genetic methods for non-invasive prostate cancer testing.
- To evaluate the utility of these methods in monitoring the efficacy of anticancer therapies.
- To assess the future perspectives and clinical integration of these advanced diagnostic techniques.
Summary:
- Immunochemical and molecular-genetic assays offer significant potential for non-invasive prostate cancer detection.
- These methods provide valuable data for monitoring patient response to anticancer treatments.
- The review synthesizes current evidence on the analytical performance and clinical applicability of these diagnostic tools.
Impact:
- Enhanced non-invasive diagnostic strategies for prostate cancer.
- Improved monitoring of anticancer therapy effectiveness, enabling personalized treatment adjustments.
- Potential to refine clinical practice guidelines and improve patient management and outcomes.
